Health Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) June 3, 2025
Health Asgard Therapeutics strengthens its Board of Directors and Advisory Board with leading experts in drug development and cancer immunotherapy June 3, 2025
Health IDEAYA Biosciences to Participate in Upcoming June 2025 Investor Relations Events June 2, 2025
Health Novoxel Inc. and GPOphtho Finalize Strategic Agreement to Deliver Breakthrough Dry Eye Treatments and Aesthetic Procedures to Eyecare Physicians Nationwide June 1, 2025
Health ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma June 1, 2025
Search
Health
June 3, 2025
June 3, 2025
June 3, 2025
June 3, 2025
June 3, 2025
June 2, 2025
June 2, 2025
June 2, 2025
June 1, 2025
June 1, 2025
